- Report
- May 2024
- 137 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- July 2023
- 93 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- June 2022
- 31 Pages
Global
From €1909EUR$2,000USD£1,599GBP
Bacterial Conjunctivitis is an infection of the eye caused by bacteria. It is a common eye infection, especially in children, and is usually treated with antibiotics. Infectious Diseases Drugs are used to treat a variety of bacterial, viral, and fungal infections. Bacterial Conjunctivitis Drugs are a subset of Infectious Diseases Drugs, and are used to treat bacterial conjunctivitis. These drugs are typically topical antibiotics, such as ointments, drops, or gels, which are applied directly to the eye.
The Bacterial Conjunctivitis Drug market is a subset of the larger Infectious Diseases Drug market. It is a competitive market, with many companies offering products to treat bacterial conjunctivitis. Some of the major players in the market include Allergan, Bausch + Lomb, Merck, Pfizer, and Novartis. Other companies, such as Alcon, Santen, and Sun Pharmaceuticals, also offer products for the treatment of bacterial conjunctivitis. Show Less Read more